Receptor Tyrosine Kinase Kit and Gastrointestinal Stromal Tumours: An Overview

E-ISSN： 1875-533x|18|19|2893-2903

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.19, 2011-06, pp. : 2893-2903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of gastrointestinal stromal tumours

By Eisenberg Burton L von Mehren Margaret

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 869-874

Informa Healthcare

Access to resources Recommend Favorite

The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy

By Anderson MR Jankowski JAZ

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 577-592

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Factors in Surgically Managed Gastrointestinal Stromal Tumours

By Wu X-J Zhang R-X Chen G Fang Y-J Ding P-R Li L-R Lu Z-H Kong L-H Pan Z-Z Wan D-S

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1904-1911

Field House Publishing

Access to resources Recommend Favorite

Imatinib Mesylate: In the Treatment of Gastrointestinal Stromal Tumours

By Croom K.F. Perry C.M.

Drugs, Vol. 63, Iss. 5, 2003-01 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?

By Nilsson Bengt Nilsson Ola Ahlman Håkan

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 457-468

Informa Healthcare

Access to resources Recommend Favorite